Search all bills

TOTAL RESULTS: 4139

• Australian Institute of Health and Welfare Amendment Bill 2018

  Track (What's this?)

  Date

  28 Mar 2018 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Amends the

  Australian Institute of Health and Welfare Act 1987

  to implement certain recommendations of the Independent Review of the Australian Institute of Health and Welfare (AIHW) by: replacing the representative-based structure of the AIHW board with a skills-based board comprised of members from a range of different fields; providing for board members to be appointed by the minister rather than the Governor-General; providing for members to be appointed for terms of up to five years; specifying employment conditions and administrative arrangements in relation to the membership and operation of the board; and making transitional arrangements. 

  Bill | Explanatory Memorandum

• Medicare Levy Amendment (Excess Levels for Private Health Insurance Policies) Bill 2018

  Track (What's this?)

  Date

  28 Mar 2018 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Part of a package of three bills to increase maximum excess levels for private hospital cover, the bill amends the

  Medicare Levy Act 1986

  to: give effect to new maximum voluntary excess levels that are permitted for a complying health insurance policy to exempt the holder from the Medicare Levy Surcharge; and remove the grandfathering provisions that provided Medicare levy surcharge exemptions for certain policies that pre-date the commencement of the

  Private Health Insurance Act 2007

  . 

  Bill | Explanatory Memorandum

• Private Health Insurance Legislation Amendment Bill 2018

  Track (What's this?)

  Date

  28 Mar 2018 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Part of a package of three bills to increase maximum excess levels for private hospital cover, the bill amends the:

  Private Health Insurance Act 2007

  to: increase maximum excess levels for products providing an exemption from the Medicare levy surcharge; enable age-based premium discounts for hospital cover; enable private health insurers to cover travel and accommodation costs for regional Australians as part of a hospital treatment; require insurers to maintain up to date information about complying health insurance products in the form of a ‘private health information statement’; require the minister to assess and determine whether or not to include a private hospital in a class of hospitals eligible for second-tier default benefits; and enable insurers to terminate products and transfer affected policy-holders to new products;

  Age Discrimination Act 2004

  to enable age-based premium discounts to be made available to younger people; and

  Ombudsman Act 1976

  to provide the Private Health Insurance Ombudsman with powers to conduct inspections and audits at the premises of insurers or brokers. Also includes transitional provisions relating to the treatment of benefit limitation period inclusive policies. 

  Bill | Explanatory Memorandum

• National Health Amendment (Pharmaceutical Benefits—Budget and Other Measures) Bill 2017

  Track (What's this?)

  Date

  18 Oct 2017 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Amends the

  National Health Act 1953

  to: increase the current statutory price reduction that applies when the first new brand of an existing pharmaceutical item is listed on the Pharmaceutical Benefits Scheme (PBS); extend and introduce statutory price reductions applying on certain anniversaries of an F1 formulary drug being listed on the PBS; introduce ministerial discretion in relation to the application of statutory price reductions in certain circumstances; make minor amendments to price disclosure arrangements; provide new circumstances whereby a new presentation of a brand of pharmaceutical item may be listed without being subject to a new brand statutory price reduction; continue the operation of the Australian Community Pharmacy Authority and the pharmacy location rules beyond 30 June 2020; and make technical amendments. 

  Bill | Explanatory Memorandum

• Therapeutic Goods (Charges) Amendment Bill 2017

  Track (What's this?)

  Date

  14 Sep 2017 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Introduced with the Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017, the bill amends the

  Therapeutic Goods (Charges) Act 1989

  to: enable regulations to be made prescribing an annual charge for a conformity assessment body determination payable by the Australian corporation that is the subject of the determination; provide that the obligation for a conformity assessment body to pay an annual charge continues during a period in which the conformity assessment body determination is suspended; and ensure that the annual charges prescribed for provisionally registered goods also apply to provisionally registered goods entered in the Australian Register of Therapeutic Goods. 

  Bill | Explanatory Memorandum

• Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017

  Track (What's this?)

  Date

  14 Sep 2017 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Introduced with the Therapeutic Goods (Charges) Amendment Bill 2017, the bill amends the:

  Therapeutic Goods Act 1989

  to: introduce a new approval pathway for prescription medicines by creating a class of therapeutic good to be known as ‘provisionally registered goods’; allow the minister to specify, by legislative instrument, permitted indications for use with listed medicines; establish an additional pathway for intermediate risk medicines through a new application and assessment process for sponsors of listed complementary medicines seeking to use indications that fall outside the permitted indications list; strengthen monitoring powers in relation to biologicals; implement stronger compliance and enforcement powers and graduated penalties for non-compliant behaviours; remove the distinctions between advertisements for therapeutic goods for which an approval is, or is not, required; enable the secretary to utilise the work of comparable overseas regulators in the course of making assessments of medical devices; enable the secretary to publish information in relation to Australian conformity assessment bodies; align the secretary’s powers relating to conformity assessment certificates issued by Australian conformity assessment bodies and conformity assessment certificates issued by the secretary; clarify that the secretary has the power to refuse an application for including medicines, biologicals and medical devices in the Australian Register of Therapeutic Goods prior to evaluating the application if it does not meet the application requirements; and make minor amendments to achieve consistency of regulatory requirements between different types of therapeutic goods and make other minor changes; and

  Broadcasting Services Act 1992

  to make consequential amendments. 

  Bill | Explanatory Memorandum

• Industrial Chemicals (Consequential Amendments and Transitional Provisions) Bill 2017

  Track (What's this?)

  Date

  01 Jun 2017 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Part of a package of six bills to establish a new national regulatory scheme for industrial chemicals, the bill: repeals the

  Industrial Chemicals (Notification and Assessment) Act 1989

  ,

  Industrial Chemicals (Registration Charge—Customs) Act 1997

  ,

  Industrial Chemicals (Registration Charge—Excise) Act 1997

  and

  Industrial Chemicals (Registration Charge—General) Act 1997

  ; makes consequential amendments to the

  Agricultural and Veterinary Chemicals Act 1994

  ,

  Criminal Code Act 1995

  and

  Trans-Tasman Mutual Recognition Act 1997

  ; and provides for transitional arrangements. 

  Bill | Explanatory Memorandum

• Industrial Chemicals (Notification and Assessment) Amendment Bill 2017

  Track (What's this?)

  Date

  01 Jun 2017 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Part of a package of six bills to establish a new national regulatory scheme for industrial chemicals, the bill amends the

  Industrial Chemicals (Notification and Assessment) Act 1989

  to: amend the definition of a new synthetic polymer to align it with international approaches to regulation; amend the notification requirements for new chemicals; exempt polymers of low concern from notification requirements; remove certain annual reporting requirements; and make consequential amendments. 

  Bill | Explanatory Memorandum

• Industrial Chemicals Bill 2017

  Track (What's this?)

  Date

  01 Jun 2017 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Part of a package of six bills to establish a new national regulatory scheme for industrial chemicals, the bill establishes a legislative framework for the Australian Industrial Chemicals Introduction Scheme (AICIS) by: establishing the scheme and an Executive Director; defining an industrial chemical; requiring introducers of industrial chemicals to be registered; establishing a system of risk-based categorisation of industrial chemical introductions; providing a framework for the initiation of evaluations of industrial chemicals; establishing the Australian Inventory of Industrial Chemicals; specifying certain information and reporting obligations; enabling the protection of confidential business information; enabling AICIS to monitor compliance; implementing Australian obligations under certain international agreements; and establishing the power for the minister to make rules. Also bans animal testing for new chemical ingredients of cosmetics. 

  Bill | Explanatory Memorandum

• Industrial Chemicals Charges (Customs) Bill 2017

  Track (What's this?)

  Date

  01 Jun 2017 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health 

  Summary

  Part of a package of six bills to establish a new national regulatory scheme for industrial chemicals, the bill imposes an annual charge on the registration of introducers of industrial chemicals, to the extent that it is a duty of customs. 

  Bill | Explanatory Memorandum